Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research focused on Minimal residual disease and Venetoclax, with related work in Hematopoietic cell, Cumulative incidence, Myeloid leukemia. Notable publications include 'Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML', 'Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations', and 'FLA‐IDA salvage chemotherapy combined with a seven‐day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia'.
Clonal relapse dynamics in acute myeloid leukemia following allogeneic hematopoietic cell transplantation
Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations
FLA‐IDA salvage chemotherapy combined with a seven‐day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML